Wikidata

(Q61957286)

English

Gene Therapy for Blindness Caused by Choroideremia

clinical trial

In more languages

Statements

title
An Open Label Dose Escalation Phase 1 Clinical Trial of Retinal Gene Therapy for Choroideraemia Using an Adeno-associated Viral Vector (AAV2) Encoding Rab-escort Protein 1 (REP1) (English)
0 references
country
United Kingdom
0 references
start time
October 2011
0 references
end time
October 2017
0 references
number of participants
14
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61957286&oldid=2091572650"